PureTech Health plc (NASDAQ:PRTC – Get Free Report) was the target of a significant drop in short interest in September. As of September 30th, there was short interest totalling 7,000 shares, a drop of 28.6% from the September 15th total of 9,800 shares. Based on an average daily volume of 4,400 shares, the short-interest ratio is currently 1.6 days.
Institutional Inflows and Outflows
A hedge fund recently bought a new stake in PureTech Health stock. AWM Investment Company Inc. purchased a new stake in PureTech Health plc (NASDAQ:PRTC – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 6,900 shares of the company’s stock, valued at approximately $197,000. Hedge funds and other institutional investors own 0.04% of the company’s stock.
Wall Street Analyst Weigh In
PRTC has been the topic of a number of analyst reports. Leerink Partnrs upgraded shares of PureTech Health to a “strong-buy” rating in a research note on Monday, September 9th. Leerink Partners began coverage on PureTech Health in a research report on Monday, September 9th. They issued an “outperform” rating and a $45.00 price objective for the company.
PureTech Health Stock Performance
Shares of PRTC stock traded up $0.04 during mid-day trading on Friday, hitting $19.60. 4,287 shares of the stock were exchanged, compared to its average volume of 4,001. The stock’s fifty day simple moving average is $21.06 and its two-hundred day simple moving average is $24.72. PureTech Health has a 12-month low of $17.08 and a 12-month high of $34.00.
PureTech Health Company Profile
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies.
See Also
- Five stocks we like better than PureTech Health
- What is the FTSE 100 index?
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Options Trading – Understanding Strike Price
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
